menu
    • menu

    Company profile for enGene

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    enGene Inc. is a biotechnology company developing a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues. The dually derived chitosan (DDX) platform has a high-degree of payload flexibility including DNA and various forms of RNA (siRNA, shRNA, lncRNA etc.) with broad tissue and disease applications. In addition to developing EG-70 for BCG-unresponsive NMIBC, enGene enGe...
    enGene Inc. is a biotechnology company developing a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues. The dually derived chitosan (DDX) platform has a high-degree of payload flexibility including DNA and various forms of RNA (siRNA, shRNA, lncRNA etc.) with broad tissue and disease applications. In addition to developing EG-70 for BCG-unresponsive NMIBC, enGene enGene is developing unique genetic medicines for respiratory indications. The company is also evolving its technology to enable applications in several mucosal tissues.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    enGeneCanada Flag
    Country
    Country
    Canada
    Address
    Address
    7171 Rue Frederick Banting Montreal, QCH4S 1Z9
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.engene.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/engene/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Engene Reports Q1 2026 Financial Results And Provides Update
    Engene Reports Q1 2026 Financial Results And Provides Update

    09 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260309831252/en/enGene-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Update

    BUSSINESSWIRE
    09 Mar 2026
    Share Share
    Engene To Join Guggenheim Biotech Summit 2026
    Engene To Join Guggenheim Biotech Summit 2026

    04 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-04/engene-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026

    PHARMIWEB
    04 Feb 2026
    Share Share
    enGene Expands Debt Facility To $125M With Hercules Capital
    enGene Expands Debt Facility To $125M With Hercules Capital

    20 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260120638572/en/enGene-Announces-Expanded-%24125-Million-Debt-Facility-with-Hercules-Capital-Inc.

    BUSINESSWIRE
    20 Jan 2026
    Share Share
    Engene Reports 2025 Financial Results And Business Update
    Engene Reports 2025 Financial Results And Business Update

    22 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251222676164/en/enGene-Reports-Full-Year-2025-Financial-Results-and-Provides-Business-Update

    BUSINESSWIRE
    22 Dec 2025
    Share Share
    enGene's Detalimogene Chosen For FDA Manufacturing Pilot Program
    enGene's Detalimogene Chosen For FDA Manufacturing Pilot Program

    02 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251202783208/en/enGenes-Detalimogene-Selected-for-FDA-Manufacturing-Pilot-Program-to-Support-Manufacturing-Readiness

    BUSINESSWIRE
    02 Dec 2025
    Share Share
    Engene To Present At Piper Sandler Healthcare Conference
    Engene To Present At Piper Sandler Healthcare Conference

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125229644/en/enGene-to-Present-at-the-Piper-Sandler-37th-Annual-Healthcare-Conference

    BUSINESSWIRE
    25 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search